Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 8, Pages 995
Publisher
MDPI AG
Online
2021-08-18
DOI
10.3390/antibiotics10080995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
- (2021) Yee-Huang Ku et al. INFECTION GENETICS AND EVOLUTION
- Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria
- (2021) David T. Davies et al. ACCOUNTS OF CHEMICAL RESEARCH
- Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model
- (2021) Mao Hagihara et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bacterial Resistance to Antimicrobial Agents
- (2021) Manuel F. Varela et al. Antibiotics-Basel
- Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence
- (2021) Onduru G. Onduru et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies
- (2021) Ilias Karaiskos et al. Expert Review of Anti-Infective Therapy
- Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in ST258 Klebsiella pneumoniae
- (2020) Marco Coppi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers
- (2020) Navita L. Mallalieu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Pharmacokinetics and Pharmacodynamics of Imipenem–Cilastatin/Relebactam Combination Therapy
- (2020) Matthew W. McCarthy CLINICAL PHARMACOKINETICS
- Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination
- (2020) Andrea Novelli et al. Expert Review of Anti-Infective Therapy
- In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
- (2020) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations
- (2020) Krisztina M. Papp-Wallace et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
- (2020) Eric Wenzler et al. Infectious Diseases and Therapy
- Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors
- (2020) Jia-Qi Li et al. BIOORGANIC CHEMISTRY
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- (2019) Shio-Shin Jean et al. DRUGS
- β-Lactamases and β-Lactamase Inhibitors in the 21st Century
- (2019) Catherine L. Tooke et al. JOURNAL OF MOLECULAR BIOLOGY
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
- (2019) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs
- (2019) Concepción González-Bello et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
- (2019) A. Huttner et al. CLINICAL MICROBIOLOGY AND INFECTION
- Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
- (2018) Matt Shirley DRUGS
- Ceftolozane/tazobactam: place in therapy
- (2018) Daniele Roberto Giacobbe et al. Expert Review of Anti-Infective Therapy
- β-lactam/β-lactamase inhibitor combinations: an update
- (2018) Kamaleddin H. M. E. Tehrani et al. MedChemComm
- Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
- (2018) Lindsay Petty et al. Infection and Drug Resistance
- Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors
- (2018) Ryan L. Crass et al. PHARMACOTHERAPY
- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and molecular characterization of β-lactamase genes in clinical isolates of Gram-negative bacteria in Southern Ecuador
- (2016) Diana Yessenia Calva Delgado et al. Brazilian Journal of Infectious Diseases
- New β-Lactamase Inhibitors in the Clinic
- (2016) Krisztina M. Papp-Wallace et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- β-Lactams and β-Lactamase Inhibitors: An Overview
- (2016) Karen Bush et al. Cold Spring Harbor Perspectives in Medicine
- β-Lactamase Inhibitors: An Update
- (2013) Jiao Chen et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections
- (2009) Alex P Betrosian et al. Expert Opinion on Drug Metabolism & Toxicology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started